DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE
» See Plans and Pricing
All Clinical Trials for Sildenafil Citrate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00123162 | Viagra in the Treatment of Primary Dysmenorrhea | Completed | National Institutes of Health (NIH) | Phase 1/Phase 2 | 2007-05-01 | The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea. |
NCT00123162 | Viagra in the Treatment of Primary Dysmenorrhea | Completed | Milton S. Hershey Medical Center | Phase 1/Phase 2 | 2007-05-01 | The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea. |
NCT00141310 | Sildenafil Citrate for the Treatment of Established Pre-Eclampsia | Terminated | Pfizer | Phase 2 | 2004-09-01 | To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia |
NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | Completed | Beth Israel Medical Center | Phase 3 | 2005-02-01 | Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction. |
NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | Completed | Icahn School of Medicine at Mount Sinai | Phase 3 | 2005-02-01 | Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction. |
NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | Completed | St. Luke's-Roosevelt Hospital Center | Phase 3 | 2005-02-01 | Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction. |
NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | Completed | Memorial Sloan Kettering Cancer Center | Phase 3 | 2005-02-01 | Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Sildenafil Citrate
Condition Name
Clinical Trial Locations for Sildenafil Citrate
Trials by Country
Clinical Trial Progress for Sildenafil Citrate
Clinical Trial Phase
Clinical Trial Sponsors for Sildenafil Citrate
Sponsor Name